Begin main content

Tetrasodium Ethylenediaminetetraacetic Acid for Locking Central Venous Access Devices in Parenteral Feeding: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: March 4, 2019
Project Number: RB1313-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of 4% tetrasodium ethylenediaminetetraacetic acid (EDTA) for locking central venous access devices?
  2. What is the cost-effectiveness of 4% tetrasodium EDTA for locking central venous access devices?
  3. What are the evidence-based guidelines regarding the use of 4% tetrasodium EDTA for central venous access devices?

Key Message

No relevant literature was found regarding tetrasodium ethylenediaminetetraacetic acid for locking central venous access devices in parenteral feeding.